somatotroph cell raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-08-19. Anything still debated is marked as such rather than presented as settled.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
Questions remain about how much of the observed fat reduction reflects direct GHRH-receptor signaling versus the downstream growth hormone and IGF-1 surge. It is also unclear whether the compound produces meaningful benefit in populations without lipodystrophy, since trials in cognitive impairment did not reach their stated goals. Long-term effects on glucose metabolism and on cardiovascular outcomes are not fully characterized. Published work generally describes effects on surrogate markers rather than on hard clinical endpoints, and independent replication of some findings is limited.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Once reconstituted, the peptide is handled as a solution and is less stable than the lyophilized powder. Aqueous solutions are commonly kept cold and used within a defined period. Buffer composition and pH influence degradation rates, with extremes of acidity or alkalinity accelerating hydrolysis. Preservatives may be added in multi-dose formats to limit microbial growth. Freezing and thawing of solutions is generally avoided because it can cause precipitation or loss of activity.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass and detects chemical modifications. Peptide mapping and amino acid analysis can verify sequence integrity. Water content is measured by Karl Fischer titration, and residual solvents may be checked by gas chromatography. These methods together support batch-to-batch consistency and routine quality control.
== Radioactivity == Natural strontium (Sr) is nonradioactive and nontoxic at levels normally found in the environment, but 90Sr is a radiation hazard. 90Sr undergoes β− decay with a half-life of 28.91 years and a decay energy of 546 keV distributed to an electron, an antineutrino, and 90Y, which in turn undergoes β− decay with a half-life of 64.05 hours and a decay energy of 2.28 MeV distributed to an electron, an antineutrino, and occasionally a gamma ray, leaving stable 90Zr. The gamma-emitting branches are so weak that for most purposes 90Sr and 90Y can be considered pure beta particle emitters.
=== Modeling === Models inform the design of engineered biological systems by better predicting system behavior prior to fabrication. Synthetic biology benefits from better models of how biological molecules bind substrates and catalyze reactions, how DNA encodes the information needed to specify the cell and how multi-component integrated systems behave. Multiscale models of gene regulatory networks focus on synthetic biology applications. Simulations can model all biomolecular interactions in transcription, translation, regulation and induction of gene regulatory networks.
It was the country's only NGO specializing in media issues, Internet access, and media monitoring during election campaigns. It had operated without government approval, and had monitored violations of journalists' rights and had taken up the cause of the ban on the dissemination of many newspapers and magazines. Ba'athist Syrian security forces arrested and beat up protestors on 15 June 2020. The protest started on 7 June 2020, in front of the governorate center against government's failure of handling economic downfall, deteriorating living conditions and corruption. HRW appealed the Syrian authority to release the peacefully protesting detainees. Pro-regime journalists who were allowed to report within the country were arrested by security forces over social media posts or ambiguous charges like being "out of line".
=== Side effects of photobiomodulation therapy === While Photobiomodulation (PBM) therapy is generally considered safe, there are infrequent instances of immediate adverse effects. Common side effects associated with this form of light therapy can include itching, the appearance of red spots, congestion along the deep external auditory canal wall, and mild allergic reactions. These side effects are typically transient and resolve without intervention.
Sources: en.wikipedia.org
== Background == This was the first of the new President Trump's executive orders and was a mass undoing of the previous president's policies on a wide range of issues. Its core effect was the rescinding of several executive orders ordered by President Biden. It was followed that day by 25 other executive orders covering a wide range of policies and was signed in an open to the public event with attendance by Vice President JD Vance.
=== 21st century === The West China University of Medical Sciences merged with Sichuan University in 2000. The dental school and hospital adopted their current Sichuan University names in 2001, becoming the West China School of Stomatology and the West China Hospital of Stomatology. A new clinical building was completed in 2009, followed by a dedicated research building in 2010. During the 2000s and 2010s, the institution also expanded its national research infrastructure, including laboratories in oral diseases, regenerative medicine and clinical research. In 2020, the National Health Commission entrusted the institution to serve as one of the three National Centers for Stomatology (国家口腔医学中心) in the country. The stomatology national-center system was designed to concentrate expertise in the diagnosis and treatment of complex oral diseases, professional training, clinical research, standards development, and quality control.
Gloria Clanin; Gish, Duane T.; Earl Snellenberger; Bonita Snellenberger (1992). Dinosaurs by Design. Green Forest, Arkansas: Master Books. ISBN 0-89051-165-9. D. Gish (1993). Creation Scientists Answer Their Critics. El Cajon, California: Institute for Creation Research. ISBN 0-932766-28-5. Gish, Duane T. (1995). Teaching Creation Science in Public Schools. El Cajon, Calif: Institute for Creation Research. ISBN 0-932766-36-6. Gish, Duane T. (1995). Evolution: The Fossils Still Say No!. Master Books. p. 277. ISBN 0-89051-112-8.
== Preparation == Balbacua has numerous variations when it comes to the spices and secondary ingredients used. A common aspect of the dish, however, is the use of collagen-rich parts of beef, including oxtail, skin, knuckles, and other cartilaginous beef cuts in addition to regular beef cuts. These are cooked for around four to six hours until the meat is falling off the bones and is very tender. The collagen from the skin and cartilage thickens the soup into a gelatinous consistency. Common spices used include garlic, onion, black or white pepper, labuyo chilis, ginger or turmeric, annatto (achuete) oil, star anise (sangke), fermented black beans (tausi), bay leaves, coconut vinegar (sukang tuba), lemongrass (tanglad), fish sauce (patis), leeks or scallions, soy sauce or salt, calamansi, and so on. Secondary ingredients are similarly variable, including pechay, ground peanuts, baked beans, tomatoes, and saba bananas. Based on the ingredients, balbacua has sometimes been described as being a cross between puchero and kare-kare dishes. Balbacua is typically served with white rice or with misua or miki noodles (the latter variants are differentiated as balbacua con misua and balbacua con miki, respectively).
==== Absorption ==== Propranolol is rapidly and completely absorbed, with peak plasma levels achieved about 2 hours (range 1–3 hours) after ingestion. Its oral bioavailability is approximately 25%. Despite complete absorption, propranolol has a variable bioavailability due to extensive first-pass metabolism. Hepatic impairment therefore increases its bioavailability. Therapeutic plasma concentrations are typically between 0.02 and 0.3 mg/L. Toxicity has been reported at concentrations of 1 mg/L and above, with coma or death associated with concentrations of 4 to 10 mg/L and above. Coadministration with food appears to enhance bioavailability but does not hasten its time to peak levels. Propranolol can be absorbed along the whole intestine with the main absorption site being the colon, which means people who have lost their colon due to surgery may absorb less propranolol. Propranolol shows marked interindividual variability in pharmacokinetics, with propranolol levels varying 20-fold in different individuals.
Sources: en.wikipedia.org
Upon learning it was Tetsu, Baachiyo attempts to force himself on the officer before the Dekarangers arrest the alien. Baachiyo is voiced by Motomu Kiyokawa (清川元夢, Kiyokawa Motomu) in his immature form and Taiki Matsuno (松野 太紀, Matsuno Taiki) in his adult form. Spiritian Byoi (スピリト星人ビョーイ, Supirito Seijin Byōi): A gas-based criminal from Planet Spirit who is capable of possessing other beings. He secretly possesses Ban, but is forced out by Hakutaku. Byoi retaliates by piloting a cyclops-themed flight-capable Kaijuki called Hunter Jet (ハンタージェット, Hantā Jetto), but is deleted by Deka Bike Robo. Byoi is voiced by Katsumi Shiono. Beesian Beeling (ビース星人ビーリング, Bīsu Seijin Bīringu): A lizard-themed fighter, from Planet Bees, in Durden's illegal fight club who consumes the illegal steroid Megagesterine and fights Hoji and Tetsu. Beeling is voiced by Yoshimitsu Shimoyama (下山 吉光, Shimoyama Yoshimitsu). Barigean Milibar (バリゲ星人ミリバル, Barige Seijin Miribaru): A aerokinetic cycloptic thief and serial killer from Planet Barige who previously robbed criminals to raise money for orphans before he became reckless. He enlarges himself, but is deleted by Super Dekaranger Robo. During the events of the crossover film Tokusou Sentai Dekaranger vs. Abaranger, Saunaginnan resurrects Milibar, who is subsequently killed by Deka Red, Blue, and Green, and Abare Yellow. Milibar is voiced by Masaru Ōbayashi (大林 勝, Ōbayashi Masaru), who also portrays his human form.
The escalation of American threats against Greenland has been linked by several commentators to the apparent success of the 2026 United States intervention in Venezuela. Some commentators have also linked the Greenland Crisis to Trump's threats against Canada. Former Premier of Ontario and Permanent Representative of Canada to the United Nations Bob Rae stated that Trump "doesn't take Canada's sovereignty seriously", while former Principal Secretary to the Prime Minister Gerald Butts stated that, although he didn't believe Trump would invade Canada directly, "we're going to see a lot of threats, and we're going to see a lot of seeding of pro-American activity by the Americans in Canadian life". NBC News reported in mid-January 2026 that, according to senior American officials, Trump was "privately ramping up his focus on another target in the Western Hemisphere, increasingly complaining to aides in recent weeks about Canada's vulnerability to US adversaries in the Arctic". Trump's aggressive negotiation tactics have prompted comparisons with the madman theory. James D.
=== Tourne === Compared to malic and citric acids, tartaric acid is usually considered microbiologically stable. However, some species of Lactobacillus (particularly L. brevis and L. plantarum) have the potential to degrade tartaric acid in wine, reducing a wine's total acidity by 3-50%. French winemakers had long observed this phenomenon and called it tourne (meaning "turn to brown") in reference to the color change that can occur in the wine at the same time likely due to other processes at work in addition to the tartaric loss. While Lactobacillus is the most common culprit of tourne, some species of the spoilage film yeast Candida can also metabolize tartaric acid.
=== 1980–2000: Development of Viagra, Zoloft, and Lipitor === In 1981, the company received approval for Diflucan (fluconazole), the first oral treatment for severe fungal infections including candidiasis, blastomycosis, coccidiodomycosis, cryptococcosis, histoplasmosis, dermatophytosis, and pityriasis versicolor. In 1986, Pfizer acquired the worldwide rights to Zithromax (azithromycin), a macrolide antibiotic that is recommended by the Infectious Disease Society of America as a first line treatment for certain cases of community-acquired pneumonia, from Pliva. In 1989, Pfizer scientists Peter Dunn and Albert Wood created Viagra (sildenafil) for treating high blood pressure and angina, a chest pain associated with coronary artery disease. In 1991, it was patented in the United Kingdom as a heart medication. Early trials for the medication showed that it did not work for the treatment of heart disease, but volunteers in the clinical trials had increased erections several days after taking the drug. It was patented in the United States in 1996 and received approval by the Food and Drug Administration in March 1998. In December 1998, Pfizer hired Bob Dole as a spokesperson for the drug. The patents for Viagra expired in 2020. In 1991, William C. Steere, Jr. became CEO, succeeding Edmund T. Pratt Jr. In 1991 Pfizer also began marketing Zoloft (sertraline), an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class developed nine years earlier by Pfizer chemists Kenneth Koe and Willard Welch.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It acts upstream at the pituitary receptor and depends on functioning somatotroph cells to produce any effect. Growth hormone injections bypass that step and deliver the hormone directly. The pharmacokinetic profiles and the resulting feedback on the body's own secretion therefore differ.